Skip to main content

Advertisement

SpringerLink
Log in

Tuberculous meningitis in children

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

  • Initial empiric treatment for central nervous system (CNS) tuberculosis should include four antituberculous drugs until results of cultures and sensitivities are available.

  • Treatment should include isoniazid, rifampin, pyrazinamide, and either ethambutol or streptomycin. Total treatment should extend for 12 months. Daily therapy should be used for the first 2 months, followed by either twice a week treatment or continued with daily therapy for the duration with directly observed therapy (DOT) [1], Class III.

  • Pyrazinamide should be included in all treatment regimes for the first 2 months of therapy.

  • Corticosteroids should be used in the management of children with tuberculous meningitis [1]. Corticosteroids have been shown to decrease mortality, long-term neurologic complications, and permanent sequelae [2],[3], Class I. Prednisone is often used at a dosage of 1 to 2 mg/kg per day [1], Class III. Steroids should be used for 4 to 6 weeks, and then tapered over the next 2 to 3 weeks.

  • Cerebrospinal fluid (CSF) cultures and other infected sites must be aggressively pursued in order to obtain an organism for identification and sensitivities testing.

  • Cranial CT scans with contrast should be included in the early diagnostic work-up of a child with suspected CNS tuberculosis infection. Hydrocephalus is often an early finding and may be helpful in establishing the diagnosis of CNS tuberculosis.

  • Treatment of CNS tuberculosis should be for 12 months.

  • All children with CNS tuberculosis should be promptly reported to the local public health department. Public health will facilitate the case-contact study and assist with follow-up and DOT after discharge.

  • Directly observed therapy should be given for the entire treatment course [1], Class III. This is best accomplished with the collaboration of local public health services.

  • Children with tuberculous meningitis should be evaluated in follow-up monthly. Monitoring should include determining adherence to drug treatment, an interval history for signs and symptoms of disease progression, careful physical examinations and evaluation for adverse effects of drugs. Liver function tests should be obtained at baseline, 2-, 4-, 6-, and 8 weeks, and then monthly for the first several months of treatment.

  • Children with tuberculous meningitis should be tested for HIV infection, including pre- and post-test counseling [1], Class III.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Committee on Infectious Diseases: Tuberculosis. In Redbook 2000. Elk Grove: American Academy of Pediatrics; 2000:593–613. This is an excellent review of pulmonary and extrapulmonary tuberculosis, epidemiology, current treatment regimens, and drug-resistant tuberculous disease in children.

    Google Scholar 

  2. Girgis NI, Farid Z, Kilpatrick ME, et al.: Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J 1991, 10:179–83.

    Article  PubMed  CAS  Google Scholar 

  3. Schoeman JF, Van Zyl LE, Aubscher JA, Donald PR: Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 1997, 99:226–231.

    Article  PubMed  CAS  Google Scholar 

  4. Idriss ZH, Sinno AA, Kronfol NM: Tuberculous meningitis in childhood: 42 cases. Am J Dis Child 1976, 130:364–367.

    PubMed  CAS  Google Scholar 

  5. Lincoln EM, Sordillo SVR, Davies PA: Tuberculous meningitis in children. J Pediatr 1960, 57:807–823.

    Article  PubMed  CAS  Google Scholar 

  6. Kennedy DH, Fallon RJ: Tuberculous meningitis. JAMA 1979, 241:264–268.

    Article  PubMed  CAS  Google Scholar 

  7. Hinman AR: TB meningitis at Cleveland Metropolitan General Hospital 1959–1963. Am Rev Respir Dis 1967, 95:760–763.

    Google Scholar 

  8. Sumaya CV, Simek M, Smith MHD, et al.: Tuberculous meningitis in children during the isoniazid era. J Pediatr 1975, 87:43–49.

    Article  PubMed  CAS  Google Scholar 

  9. Molavi A, LeFrock JL: Tuberculous meningitis. Med Clin N Amer 1985, 69:315–331.

    PubMed  CAS  Google Scholar 

  10. Gutman LT: Extrapulmonary tuberculosis. Semin Pediatr Infect Dis 1993, 4:250–260.

    Google Scholar 

  11. Waecker NJ, Connor JD: Central nervous system tuberculosis in children: a review of 30 cases. Pediatr Infect Dis J 1990, 9:539–544.

    Article  PubMed  Google Scholar 

  12. Zarabi M, Sane S, Girdany BR: The chest roentgenogram in the early diagnosis of tuberculous meningitis in children. Am J Dis Child 1971, 121:389–392.

    PubMed  CAS  Google Scholar 

  13. Jacobs RF, Starke JR: Mycobacterium tuberculosis. In Principles and Practice of Pediatric Infectious Diseases. Edited by Long SS, Pickering LK, Prober CG. New York: Churchill Livingston, Inc.; 1997.

    Google Scholar 

  14. Horsburgh CR, Feldman S, Ridzon R: Practice guidelines for the treatment of tuberculosis. Clin Infect Dis 2000, 31:633–639.

    Article  PubMed  Google Scholar 

  15. Bass JB, Farer LS, Hopewell PC, et al.: Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1994, 149:1359–1374.

    Google Scholar 

  16. Centers for Disease Control: Initial therapy for tuberculosis in the era of multidrug resistance. MMWR Morb Mortal Wkly Rep 1993, 42:1–8.

    Google Scholar 

  17. Centers for Disease Control: Improving adherence to antituberculosis therapy: South Carolina and New York. MMWR Morb Mortal Wkly Rep 1993, 42:74–81.

    Google Scholar 

  18. Starke JR, Correa AG: Management of mycobacterial infection and disease in children. Pediatr Infect Dis J 1995, 14:455–470.

    Article  PubMed  CAS  Google Scholar 

  19. Escobar JA, Belsey MA, Ovenas A, et al.: Mortality from tuberculous meningitis reduced by steroid therapy. Pediatrics 1975, 56:1050.

    PubMed  CAS  Google Scholar 

  20. Starke JR: Current chemotherapy for tuberculosis in children. Infect Dis Clin N Amer 1992, 6:215–238.

    CAS  Google Scholar 

  21. Committee on Infectious Diseases: Chemotherapy for tuberculosis in infants and children. Pediatrics 1992, 89:161–165.

    Google Scholar 

  22. Antiuberculosal agents. In Drug Facts and Comparisons. Edited by Kastrup EK. St. Louis: Facts and Comparisons; 2001.

    Google Scholar 

  23. Centers for Disease Control: Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculous infection, and revision in ATS/CDC recommendations—US. MMWR Morb Mortal Wkly Rep 2001, 50:733–735.

    Google Scholar 

  24. O’Brien RJ, Long MW, Cross FS, et al.: Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis. Pediatrics 1983, 72:491–499.

    PubMed  CAS  Google Scholar 

  25. Tsagaropoulou-Stinga H, Mataki-Emmanouilidou T, Karida-Kavalioto S, Manios S: Hepatotoxic reactions in children with severe tuberculosis treated with isoniazid-rifampin. Pediatr Infect Dis J 1985, 4:270–273.

    Article  CAS  Google Scholar 

  26. Doerr CA, Starke JR, Ong LT: Clinical and public health aspects of tuberculous meningitis in children. J Pediatr 1995, 127:27–33.

    Article  PubMed  CAS  Google Scholar 

  27. Sarnaik AP, Hackbarth RM, Sanfilippo DJ, Canady A: Acute hydrocephalus in Stage III tuberculous meningitis. International Pediatr 1993, 8:446–451.

    Google Scholar 

  28. Bhagwati SN: Ventriculoatrial shunt in tuberculous meningitis with hydrocephalus. J Neurosurg 1971, 35:309–313.

    Article  Google Scholar 

  29. Gropper MR, Schulder M, Sharan AD, Cho ES: Central nervous system tuberculosis: medical management and surgical indications. Surg Neurol 1995, 44:378–385.

    Article  PubMed  CAS  Google Scholar 

  30. Palur R: Shunt surgery for hydrocephalus in tuberculous meningitis: a long-term follow-up study. J Neurosurg 1991, 74:64–69.

    PubMed  CAS  Google Scholar 

  31. Gelabert M, Castro-Gago M: Hydrocephalus and tuberculous meningitis in children. Child Nerv Syst 1988, 4:268–270.

    CAS  Google Scholar 

  32. Jacobs RF: Intensive short course chemotherapy for tuberculous meningitis. Pediatr Infect Dis J 1992, 11:194–198.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Investigation Department, Naval Medical Center San Diego, 34800 Bob Wilson Drive, 92134, San Diego, CA, USA

    Norman J. Waecker MD

Authors
  1. Norman J. Waecker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waecker, N.J. Tuberculous meningitis in children. Curr Treat Options Neurol 4, 249–257 (2002). https://doi.org/10.1007/s11940-002-0042-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-002-0042-0

Keywords

Search

Navigation